6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Personalized Psychiatry and Precision Medicine
One-size-fits-all psychiatric care is being replaced by a more tailored approach, thanks to advancements in personalized psychiatry and precision medicine. By leveraging genetic data, biomarkers, neuroimaging, and digital phenotyping, clinicians can now better predict treatment responses, minimize adverse drug reactions, and select therapies aligned with a patient’s biological profile. This precision-driven model is particularly effective in complex disorders like bipolar depression, schizophrenia, and anxiety, where variability in symptoms and treatment outcomes has long challenged practitioners. Emerging pharmacogenetic tests and machine learning algorithms are accelerating diagnosis and guiding intervention. Personalized psychiatry is moving beyond theory into clinical reality, allowing more efficient, individualized, and enduring care pathways for mental health patients.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States